205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

• Burcu Yigit,
• Xavier Michelet,
• Darrian Moskowitz,
• Marc Van Dijk,
• Antoine Tanne

Affiliations

Burcu Yigit

Agenus, Lexington, MA, USA

Xavier Michelet

Agenus, Lexington, MA, USA

Darrian Moskowitz

Agenus, Lexington, MA, USA

Marc Van Dijk

4AgenTus Therapeutics, Inc., Cambridge, UK

Antoine Tanne

2Agenus, Lexington, MA, USA